Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
暂无分享,去创建一个
A. Lohse | B. Fehse | K. Riecken | T. Volz | M. Dandri | S. Urban | C. Sureau | Joerg Petersen | M. Lütgehetmann | O. Bhadra | L. Allweiss | K. Giersch | J. Petersen
[1] A. Lohse,et al. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo , 2017, Gut.
[2] M. Levrero,et al. Aiming for cure in HBV and HDV infection. , 2016, Journal of hepatology.
[3] Thorsten Lehr,et al. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study. , 2016, Journal of hepatology.
[4] Peng Jin,et al. Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth. , 2016, Cell stem cell.
[5] A. Lohse,et al. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. , 2015, Journal of hepatology.
[6] S. Davies,et al. Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis , 2015, PloS one.
[7] A. Lohse,et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism , 2014, Hepatology.
[8] M. Fälth,et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.
[9] Sumedha Bagga,et al. Cell Cycle Regulation During Viral Infection , 2014, Methods in molecular biology.
[10] S. Polywka,et al. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. , 2014, Journal of hepatology.
[11] S. Alavian,et al. Hepatitis delta: the rediscovery. , 2013, Clinics in liver disease.
[12] A. Lohse,et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. , 2013, Journal of hepatology.
[13] Wenhui Li,et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.
[14] R. Idilman,et al. Entecavir treatment of chronic hepatitis D. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Ghabrial,et al. Discovery of Novel dsRNA Viral Sequences by In Silico Cloning and Implications for Viral Diversity, Host Range and Evolution , 2012, PloS one.
[16] Michael Thomaschewski,et al. RGB marking with lentiviral vectors for multicolor clonal cell tracking , 2012, Nature Protocols.
[17] A. Lohse,et al. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation , 2012, Hepatology.
[18] M. Manns,et al. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation. , 2012, Journal of hepatology.
[19] I. Sporea,et al. Weight-based dosing regimen of peg-interferon α-2b for chronic hepatitis delta: a multicenter Romanian trial. , 2011, Journal of gastrointestinal and liver diseases : JGLD.
[20] Stanley M. Lemon,et al. Hepatitis C Virus Infection Causes Cell Cycle Arrest at the Level of Initiation of Mitosis , 2011, Journal of Virology.
[21] Michael Thomaschewski,et al. RGB marking facilitates multicolor clonal cell tracking , 2011, Nature Medicine.
[22] D. Harnois. Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta , 2011 .
[23] A. Alibrandi,et al. Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta Viruses , 2010, Journal of Virology.
[24] M. Buti,et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. , 2010, Journal of hepatology.
[25] S. Litwin,et al. Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.
[26] [EASL clinical practice guidelines. Management of chronic hepatitis B]. , 2009, Gastroenterologie clinique et biologique.
[27] U. Haberkorn,et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein , 2008, Nature Biotechnology.
[28] E. Nicolas,et al. Assembly of Hepatitis Delta Virus: Particle Characterization, Including the Ability To Infect Primary Human Hepatocytes , 2007, Journal of Virology.
[29] D. Häussinger,et al. Treatment of chronic hepatitis delta with pegylated interferon‐α2b , 2006 .
[30] A. Andriulli,et al. Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta , 2006, Hepatology.
[31] D. Häussinger,et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[32] H. Wu,et al. Post-translational modification of delta antigen of hepatitis D virus. , 2006, Current topics in microbiology and immunology.
[33] D. Häussinger,et al. Treatment of chronic hepatitis delta with pegylated interferon-a 2 b , 2006 .
[34] M. Manns,et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study , 2005, Alimentary pharmacology & therapeutics.
[35] M. Lai. RNA Replication without RNA-Dependent RNA Polymerase: Surprises from Hepatitis Delta Virus , 2005, Journal of Virology.
[36] Jinhong Chang,et al. Development of a Novel System To Study Hepatitis Delta Virus Genome Replication , 2005, Journal of Virology.
[37] S. Litwin,et al. INAUGURAL ARTICLES: Hepatocyte turnover during resolution of a transient hepadnaviral infection , 2003 .
[38] E. Christensen,et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B , 2000, Gut.
[39] J. Taylor. Replication of human hepatitis delta virus: influence of studies on subviral plant pathogens. , 1999, Advances in virus research.
[40] R. Purcell,et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope , 1998, Hepatology.
[41] D. Mathieu,et al. Long‐term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis , 1995, Hepatology.
[42] J. Taylor,et al. Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus , 1994, Journal of virology.
[43] J. Taylor,et al. Introduction of hepatitis delta virus into animal cell lines via cationic liposomes , 1994, Journal of virology.
[44] P. Chen,et al. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles , 1991, Journal of virology.
[45] Ding‐Shinn Chen,et al. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] Michael Houghton,et al. Structure, sequence and expression of the hepatitis delta (δ) viral genome , 1986, Nature.
[47] M. Houghton,et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome. , 1986, Nature.
[48] R. Purcell,et al. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Dumont,et al. European Association for the Study of the Liver , 1971 .